Using Polygenic Risk Scores to Establish Endophenotypes: Considerations and Current Constraints

Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Mar;2(2):113-114. doi: 10.1016/j.bpsc.2017.01.008. Epub 2017 Mar 6.

Authors

David C Glahn¹, Andrew M McIntosh²

Affiliations

¹ Department of Psychiatry, Yale University School of Medicine, New Haven; Olin Neuropsychiatry Research Center, Institute of Living, Hartford, Connecticut. Electronic address: david.glahn@yale.edu.
² Division of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom; Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, United Kingdom.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Comment

Grants and funding